Uceris Available For UC Patients In March
On Jan 14th the Food & Drug Administration approved the drug UCERIS (Budesonide) for the induction of remission in patients with mild to moderate ulcerative colitis. Uceris can be used for patients who are not responding to other medications prescribed for Inflammatory Bowel Diseases.
"In patients that are not responding to 5-ASAs or cannot use 5-ASAs with mild to moderate disease activity, Uceris may be used as an alternative to prednisone for inducing remission," says Dr. Faten N. Aberra. "Uceris is only indicated for inducing remission for up to 8 weeks and not a maintenance medication."
The medication will be available to the public in March 2013. For more details on this new medication check out the Santarus website: http://ir.santarus.com/releasedetail.cfm?ReleaseID=733438.